Your browser doesn't support javascript.
loading
Somatic copy number alteration predicts clinical benefit of lung adenocarcinoma patients treated with cytokine-induced killer plus chemotherapy.
Kou, Fan; Wu, Lei; Zhu, Ye; Li, Baihui; Huang, Ziqi; Ren, Xiubao; Yang, Lili.
Afiliação
  • Kou F; Department of Immunology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
  • Wu L; National Clinical Research Center for Cancer, Tianjin, China.
  • Zhu Y; Key Laboratory of Cancer Immunology and Biotherapy, Tianjin, China.
  • Li B; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.
  • Huang Z; Tianjin's Clinical Research Center for Cancer, Tianjin, China.
  • Ren X; Department of Immunology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
  • Yang L; National Clinical Research Center for Cancer, Tianjin, China.
Cancer Gene Ther ; 29(8-9): 1153-1159, 2022 08.
Article em En | MEDLINE | ID: mdl-35022521
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Adenocarcinoma de Pulmão / Neoplasias Pulmonares Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Adenocarcinoma de Pulmão / Neoplasias Pulmonares Idioma: En Ano de publicação: 2022 Tipo de documento: Article